Preclinical study shows promise of systemic targeted therapy in a rare form of cancer July 20, 2024 Health Trends, Health Trends - UK Treatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600E PMP-PDX tumors without impacting in apoptosis. a–d) Mice bearing subcutaneous BRAF mutant PMP-PDX tumors (PMP5.1) were treated with… Source link
July 20, 2024 Health Trends, Health Trends - UK Treatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600E PMP-PDX tumors without impacting in apoptosis. a–d) Mice bearing subcutaneous BRAF mutant PMP-PDX tumors (PMP5.1) were treated with… Source link
